Cytosorbents Corporation Blog | Talkmarkets | Page 1
No data available
No data available

People who follow this stock (17)

Latest Posts

About This Stock More About This Stock
Biotech Digest – JAZZ Reports Positive Results, CTSO Inks New Contract, AMGN Forges Collaboration
Article By: KKD Healthcare Analytics
Tuesday, April 25, 2017 10:15 AM EST
Capricor Therapeutics announced encouraging six-month results in a Phase 1/2 clinical trial. Jazz Pharmaceuticals reported results from its Phase 2/3 clinical trial. Amgen announced its new collaboration with Novartis.
In this article: NVS, EAPH, ACHN, JAZZ, AMGN, CANF, CAPR, CTSO
Read
CytoSorbents Continues Despite Disappointing Financials
Article By: Anthony Alfidi
Monday, January 4, 2016 1:28 AM EST
CytoSorbents Corporation has a brand new approach to removing blood impurities in critically ill patients.
In this article: BAX, FMS, LLY, CTSO
Read
Four Small-Cap Medtechs Primed For Outsize Returns: Zacks' Brian Marckx
Article By: The Life Sciences Report
Thursday, July 16, 2015 8:05 AM EST
In the U.S., the medical device and diagnostics industry has been burdened with conflicting regulations that have delayed commercialization and complicated reimbursement.
In this article: AEMD, CEMI, CTSO, ZMSPF Also: ALR, CODGF, OSUR
Read

PARTNER HEADLINES

Latest Tweets for $CTSO

No tweets yet!